Bioadaptives (BDPT) Change in Accured Expenses (2014 - 2026)

Bioadaptives has disclosed Change in Accured Expenses across 12 years of filings, most recently posting $2978.0 for Q1 2026.

• Change in Accured Expenses for Q1 2026 came in at $2978.0, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $56245.0 (up 63.41% YoY), and the FY2025 annual result was $53267.0, up 18.82% from the prior year.
• Change in Accured Expenses came in at $2978.0 for Q1 2026 at Bioadaptives, up from $1957.0 in the prior quarter.
• In the past five years, Change in Accured Expenses ranged from a high of $89608.0 in Q1 2022 to a low of -$16261.0 in Q3 2023.
• The 5-year median for Change in Accured Expenses is $10993.0 (2022), against an average of $20282.0.
• Across the five-year window, Change in Accured Expenses soared 652.39% in 2022 and tumbled 210.27% in 2023, its largest moves.
• Bioadaptives' Change in Accured Expenses stood at $11575.0 in 2022, then jumped by 246.9% to $40154.0 in 2023, then plunged by 76.24% to $9542.0 in 2024, then plunged by 79.49% to $1957.0 in 2025, then surged by 52.17% to $2978.0 in 2026.
• The last three Change in Accured Expenses figures came in at $2978.0 (Q1 2026), $1957.0 (Q4 2025), and $26687.0 (Q3 2025), per Business Quant data.